ArticleTrials2022

Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study.

Daisuke Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.